Literature DB >> 24738969

Positive correlation between the efficiency of induced pluripotent stem cells and the development rate of nuclear transfer embryos when the same porcine embryonic fibroblast lines are used as donor cells.

Bingteng Xie1, Jianyu Wang, Shichao Liu, Jiaqiang Wang, Binghua Xue, Jingyu Li, Renyue Wei, Yanhua Zhao, Zhonghua Liu.   

Abstract

Induced pluripotent stem cells (iPSCs) and nuclear transfer (NT) are two of the primary routes to reprogram differentiated cells back to the pluripotent state. However, it is still unknown whether there is any correlation between the reprogramming efficiency of iPSCs and NT if the same donor cells are employed. In this study, six porcine embryonic fibroblast (PEF) lines from Landrace (L1, L6, L9) or Congjiang local pigs (C4, C5, C6) were used for iPSC induction and NT. Furthermore, the resultant iPSCs from four PEF lines (L1, L6, C4, and C5) were used for NT (iPSC-NT), and the expression of exogenous genes was detected in iPSC-NT embryos by real-time PCR. The results showed that the efficiency of iPSC lines established from different PEF lines were significantly different. When the same PEF lines were used as donor cells for NT, the blastocysts rates were also different among different PEF lines and positively related with iPSCs induction efficiency. When the iPSCs were used as donor cells for NT, compared with the source PEFs, the blastocysts rates were significantly decreased. Real-time PCR results indicated that exogenous genes (Oct4, c-Myc) continued to be expressed in iPSC-NT embryos. In summary, our results demonstrate that there was a positive correlation between iPSCs and NT reprogramming efficiency, although the mechanism of these two routes is different. This may provide a new method to select the appropriate donor cells for inducing iPSCs.

Entities:  

Mesh:

Year:  2014        PMID: 24738969      PMCID: PMC4030655          DOI: 10.1089/cell.2013.0080

Source DB:  PubMed          Journal:  Cell Reprogram        ISSN: 2152-4971            Impact factor:   1.987


  38 in total

1.  Piglets cloned from induced pluripotent stem cells.

Authors:  Nana Fan; Jijun Chen; Zhouchun Shang; Hongwei Dou; Guangzhen Ji; Qingjian Zou; Lu Wu; Lixiazi He; Fang Wang; Kai Liu; Na Liu; Jianyong Han; Qi Zhou; Dengke Pan; Dongshan Yang; Bentian Zhao; Zhen Ouyang; Zhaoming Liu; Yu Zhao; Lin Lin; Chongming Zhong; Quanlei Wang; Shouqi Wang; Ying Xu; Jing Luan; Yu Liang; Zhenzhen Yang; Jing Li; Chunxia Lu; Gábor Vajta; Ziyi Li; Hongsheng Ouyang; Huayan Wang; Yong Wang; Yang Yang; Zhonghua Liu; Hong Wei; Zhidong Luan; Miguel A Esteban; Hongkui Deng; Huanming Yang; Duanqing Pei; Ning Li; Gang Pei; Lin Liu; Yutao Du; Lei Xiao; Liangxue Lai
Journal:  Cell Res       Date:  2012-12-18       Impact factor: 25.617

2.  Tbx3 and Nr5α2 play important roles in pig pluripotent stem cells.

Authors:  Jianyu Wang; Qi Gu; Jie Hao; Yundan Jia; Binghua Xue; Honghong Jin; Jing Ma; Renyue Wei; Tang Hai; Qingran Kong; Gerelchimeg Bou; Ping Xia; Qi Zhou; Liu Wang; Zhonghua Liu
Journal:  Stem Cell Rev Rep       Date:  2013-10       Impact factor: 5.739

Review 3.  Donor cell differentiation, reprogramming, and cloning efficiency: elusive or illusive correlation?

Authors:  B Oback; D N Wells
Journal:  Mol Reprod Dev       Date:  2007-05       Impact factor: 2.609

4.  Significant improvement of mouse cloning technique by treatment with trichostatin A after somatic nuclear transfer.

Authors:  Satoshi Kishigami; Eiji Mizutani; Hiroshi Ohta; Takafusa Hikichi; Nguyen Van Thuan; Sayaka Wakayama; Hong-Thuy Bui; Teruhiko Wakayama
Journal:  Biochem Biophys Res Commun       Date:  2005-12-09       Impact factor: 3.575

Review 5.  Chromatin and epigenetic modifications during early mammalian development.

Authors:  Karlla Mason; Zichuan Liu; Tiphaine Aguirre-Lavin; Nathalie Beaujean
Journal:  Anim Reprod Sci       Date:  2012-08-11       Impact factor: 2.145

6.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

7.  A molecular roadmap of reprogramming somatic cells into iPS cells.

Authors:  Jose M Polo; Endre Anderssen; Ryan M Walsh; Benjamin A Schwarz; Christian M Nefzger; Sue Mei Lim; Marti Borkent; Effie Apostolou; Sara Alaei; Jennifer Cloutier; Ori Bar-Nur; Sihem Cheloufi; Matthias Stadtfeld; Maria Eugenia Figueroa; Daisy Robinton; Sridaran Natesan; Ari Melnick; Jinfang Zhu; Sridhar Ramaswamy; Konrad Hochedlinger
Journal:  Cell       Date:  2012-12-21       Impact factor: 41.582

8.  Proliferation rate of somatic cells affects reprogramming efficiency.

Authors:  Yongyu Xu; Xiaoyuan Wei; Min Wang; Ru Zhang; Yanbin Fu; Mingzhe Xing; Qiuhong Hua; Xin Xie
Journal:  J Biol Chem       Date:  2013-02-25       Impact factor: 5.157

9.  Efficient generation of integration-free ips cells from human adult peripheral blood using BCL-XL together with Yamanaka factors.

Authors:  Rui-Jun Su; David J Baylink; Amanda Neises; Jason B Kiroyan; Xianmei Meng; Kimberly J Payne; Benjamin Tschudy-Seney; Yuyou Duan; Nancy Appleby; Mary Kearns-Jonker; Daila S Gridley; Jun Wang; K-H William Lau; Xiao-Bing Zhang
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

10.  Generating a non-integrating human induced pluripotent stem cell bank from urine-derived cells.

Authors:  Yanting Xue; Xiujuan Cai; Linli Wang; Baojian Liao; Hui Zhang; Yongli Shan; Qianyu Chen; Tiancheng Zhou; Xirui Li; Jundi Hou; Shubin Chen; Rongping Luo; Dajiang Qin; Duanqing Pei; Guangjin Pan
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more
  2 in total

Review 1.  Pluripotent stem cells and livestock genetic engineering.

Authors:  Delia A Soto; Pablo J Ross
Journal:  Transgenic Res       Date:  2016-02-19       Impact factor: 2.788

Review 2.  Perspectives of pluripotent stem cells in livestock.

Authors:  Dharmendra Kumar; Thirumala R Talluri; Naresh L Selokar; Iqbal Hyder; Wilfried A Kues
Journal:  World J Stem Cells       Date:  2021-01-26       Impact factor: 5.326

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.